Cytax 260mg Injection
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Paclitaxel (260mg)
Overview Cytax 260mg Injection
Oncaspar, a 260mg injectable antineoplastic agent, treats breast, pancreatic, and non-small cell lung cancers. Administered intravenously by healthcare professionals, the dosage and frequency are individually determined by your physician based on your condition and may vary. Strict adherence to the prescribed regimen is crucial, as incorrect usage or overdose can lead to severe adverse reactions. While therapeutic effects might not be immediately apparent, requiring weeks or months, discontinuation should only occur under medical supervision. Typical side effects include nausea, vomiting, and fatigue; however, serious reactions like edema (swelling of hands and face), alopecia (hair loss), and weight increase are possible. Concomitant medications may mitigate these, but report any unusual bruising, bleeding, pharyngitis (sore throat), oral ulcers, or pyrexia (fever) immediately. This medication can cause cytopenia (decreased blood cell counts), increasing infection risk. Regular blood tests monitor blood cell levels and hepatic (liver) function. Pre-treatment disclosure of any cardiac, hepatic, or renal (kidney) disease, or concurrent use of anti-infectives, is essential. Interactions with other medications are possible; thus, complete medication disclosure is critical. Its use is contraindicated during pregnancy and lactation; effective contraception for both partners is strongly advised throughout treatment.
Uses of Cytax 260mg Injection
Cancers of the breast, lung (non-small cell type), and pancreas.
Major Benefits of Cytax 260mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Cytax 260mg Injection:
- Nausea
- Vomiting
- Weakness
- Low blood platelets
- Rash
- Upper respiratory tract infection
- Urinary tract infection
- Bleeding
- Anemia (low number of red blood cells)
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Hair loss
- Decreased blood pressure
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Diarrhea
- Decreased white blood cell count (neutrophils)
How to use Cytax 260mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Cytax 260mg Injection works:
Cytax 260mg Injection is a cancer treatment that disrupts microtubule function, essential for cancer cell division and proliferation. This disruption inhibits cancer cell growth, ultimately leading to their demise.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol concurrently with a 260mg dose of Cytax Injection is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Administering Cytax 260mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might consider its use if the potential benefits outweigh the inherent dangers. Physician consultation is mandatory.
Breast feedingUNSAFE
Administering Cytax 260mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
The administration of Cytax 260mg Injection may induce adverse reactions that could impair driving ability. While driving between treatment cycles isn't inherently prohibited, the presence of alcohol in this medication suggests caution regarding operating a vehicle.
KidneySAFE IF PRESCRIBED
The 260mg Cytax Injection poses no known safety risk for patients with kidney disease; dosage modification is unnecessary. Nevertheless, consult your physician if you have pre-existing renal impairment.
LiverCAUTION
Individuals with hepatic impairment should use Cytax 260mg Injection cautiously, potentially requiring dosage modification. Medical advice is necessary. Cytax 260mg Injection is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Cytax 260mg Injection :
NA
Facts to Know About Cytax 260mg Injection
| Label | Value |
|---|---|
| Chemical Category | Taxane Derivatives |
| Developing Habits | No. |
| Type of Therapy | Cancer Therapeutics |
| Action Category | Taxanes: Antimicrotubule Agents |
3,018 People bought this recently